UBS AM
ASMB icon

UBS AM’s Assembly Biosciences ASMB Stock Holding History

UBS AM’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,342
Closed -$295K – 2755
2021
Q1 		$295K Buy
5,342
+1,404
+36% +$93.1K ﹤0.01% 2490
2020
Q4 		$286K Buy
3,938
+2,865
+267% +$336K ﹤0.01% 2422
2020
Q3 		$212K Sell
1,073
-821
-43% -$207K ﹤0.01% 2395
2020
Q2 		$530K Buy
1,894
+958
+102% +$224K ﹤0.01% 2103
2020
Q1 		$167K Sell
936
-1,062
-53% -$228K ﹤0.01% 2329
2019
Q4 		$490K Buy
1,998
+1,062
+113% +$196K ﹤0.01% 2244
2019
Q3 		$110K Hold
936
– – ﹤0.01% 2655
2019
Q2 		$152K Hold
936
– – ﹤0.01% 2602
2019
Q1 		$221K Buy
+936
New +$237K ﹤0.01% 2419

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

UBS AM's ASMB Position: Q2 2021 in Review

UBS AM sold out of Assembly Biosciences (ASMB) in Q2 2021, closing a stake of 5,342 shares — an estimated $295K sold.

UBS AM first reported a position in ASMB in Q1 2019 and held it in 9 quarters. The position peaked at $530K in Q2 2020. 91 funds tracked by Wall St. Rank hold ASMB as of Q2 2021.

  • UBS AM reported no remaining Assembly Biosciences position as of Q2 2021 after selling out during the quarter.
  • UBS AM sold 5,342 Assembly Biosciences shares in Q2 2021, an estimated $295K.
  • UBS AM first reported a position in Assembly Biosciences in Q1 2019 and held it in 9 quarters.
  • UBS AM's Assembly Biosciences position peaked at $530K in Q2 2020.
  • 91 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2021.

Based on UBS AM's 13F filing for Q2 2021, filed 16 Aug 2021.